Redefining Obesity Treatment: Unlocking a Unique Mechanism Providing Systemic Efficacy Without Systemic Drug Exposure
11:30 am - Thursday 10th December 2026
- Leveraging the skin as a neuro-immuno-endocrine organ to activate systemic metabolic pathways and increase energy expenditure through a first-in-class therapeutic approach
- Differentiating from traditional obesity therapies by targeting fat metabolism directly rather than suppressing appetite, creating potential opportunities both as a standalone and combination treatment strategy
- Initiating Phase 2 GDD3898, highlighting the scientific rationale, translational data, and potential to deliver meaningful weight loss while preserving metabolic health
